Red cell-derived microparticles (RMP) as haemostatic agent

Thrombosis and Haemostasis

Volumn 110, Issue 4, 2013, Pages 751-760

  Jy, Wenche ^a   Johansen, Max E ^a   Bidot Jr , Carlos ^a   Horstman, Lawrence L ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Animal bleeding models; Haemostatic agent; Red cell microparticles (RMP); RMP platelet interaction; Thromboelastography

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; HEMOSTATIC AGENT; LIPOCORTIN 5; THROMBOPLASTIN; TRYPSIN INHIBITOR;

ANIMAL MODEL; ARTICLE; BLEEDING DISORDER; BLEEDING TIME; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE MICROPARTICLE; EX VIVO STUDY; FLOW CYTOMETRY; HEMOPHILIA; HEMOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MICROPARTICLE; LIGHT SCATTERING; MALE; MEMBRANE MICROPARTICLE; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; THROMBIN TIME; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY;

ANIMAL BLEEDING MODELS; HAEMOSTATIC AGENT; RED CELL MICROPARTICLES (RMP); RMP-PLATELET INTERACTION; THROMBOELASTOGRAPHY;

ADENOSINE DIPHOSPHATE; ANIMALS; BLEEDING TIME; BLOOD COAGULATION DISORDERS; BUSULFAN; CELL SEPARATION; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; MALE; PLATELET AGGREGATION; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; THROMBELASTOGRAPHY; THROMBIN; THROMBOCYTOPENIA; THROMBOPLASTIN; TICLOPIDINE;

EID: 84884833498     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-12-0941     Document Type: Article

References (31)

1. Burnier L, Fontana P, Kwak BR, et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
2. Chang CP, Zhao J, Wiedmer T, et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993; 268: 7171-7178.
3. Ahn YS. Cell-derived microparticles: 'Miniature envoys with many faces. J Thromb Haemost 2005; 3: 884-887.
4. Tesse A, Martinez MC, Meziani F, et al. Origin and biological significance of shed-membrane microparticles. Endocr Metab Immune Disord Drug Targets 2006; 6: 287-294.
5. Morel O, Jesel L, Freyssinet JM, et al. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 15-26.
6. Andrews D, Low P. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 6: 76-82.
7. Mannucci PM. Red cells playing as activated platelets in thalassemia intermedia. J Thromb Haemost 2010; 8: 2149-2151.
8. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, et al. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993; 44: 63-65.
9. Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets. Transfusion 1996; 36: 536-542.
10. Graham SS, Gonchoroff NJ, Miller JL. Infusible platelet membranes retain partial functionality of the platelet GP Ib/IX/V receptor complex. Am J Clin Path 2001; 115: 144-147.
11. Galan AM, Bozzo J, Herndandez MR, et al. Infusible platelet membranes improve haemostasis in thrombocytopenic blood: experimental studies under flow conditions. Transfusion 2000; 40: 1074-1080.
12. Jy W, Johansen ME, Bidot Jr C, et al. Interaction of red cell microparticles (RMP) with platelets: Potential role of RMP in haemostasis and thrombosis. 53rd meeting of ASH, San Diego, CA, Dec. 4-7. Blood 2011; Suppl: Abstract 43127.
13. Ahn YS, Jy W, Johansen ME, et al. Red cell derived microparticles (RMP) as haemostatic agent to treat bleeding disorders: the mode of action of RMP. Oral presentation at XXIII ISTH Congress, July 26, 2011, Kyoto, Japan. J Thromb Haemost 2011; Suppl 9: 269, Abstract O-TU-030.
14. Jy W, Johansen ME, Horstman LL, et al. Haemostatic properties of red cell derived microparticles (RMP): Promise of universal haemostatic agent. Presented at ISTH SSC meeting in June 29, 2012, Liverpool, England. Available at: http://www.multiwebcast.com/isth/2012/ssc/20988/.
15. Jy W, Bidot Jr C, Nunez S, et al. Red Cell-Derived Microparticles (RMP) As Haemostatic Agent: Evaluation in a Rabbit Ear Bleeding Model. ASH Annual Meeting Abstracts. Blood 2012; 120: 2238.
16. Jy W, Bidot L, Jimenez JJ, et al. Thrombin generation profiles are qualitatively and quantitatively distinct in microparticles derived from red cells (RMP), platelets (PMP), and endothelia (EMP). Presented at 48th annual mtng, Amer. Soc. Hematol., Orlando, FL, Dec. 9-12. Blood 2006; 108: 499a Abstract 1759.
17. Hemker HC. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
18. Bidot L, Jy W, Bidot Jr C, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 2007; 6: 913-919.
19. Blajchman MA, Lee DH. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo haemostatic efficacy of platelets and platelet substitutes. Trans Med Rev 1997; 11: 95-105.
20. Panes O, Matus V, Saenz CG, et al. Platelets synthesize and express functional tissue factor. Blood 2007; 109: 5242-5250.
21. Skeppholm M, Mobarrez F, Malmqvist K, et al. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost 2012; 107: 1122-1129.
22. Bouchard BA., Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood 2010; 116: 854-855.
23. Van der Meijden PE, Van Schilfgaard M, Van Oerle R, et al. Plateletand erythrocyte-derived microparticles trigger thrombin generation via FXIIa. J Thromb Haemost 2012; 10: 1355-1362.
24. Rubin O, Delobel J, Prudent M, et al. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 2012; Epub ahead of print.
25. Jy W, Ahn YS, Horstman LL, et al. Microparticles from RBC (RMP) exhibit haemostatic activities in vitro and in vivo, and appear to protect ITP patients from thrombocytopenic bleeding. Presented at: XIV International Symposium on Atherosclerosis, Rome, Italy, June 18-22. Atherosclerosis 2006; Suppl 7: 291, Abstract Tu-P10:485.
26. Lominadze D, Dean WL. Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 2002; 517: 41-44.
27. Carvalho FA, Connell S, Miltenberger-Miltenyi G, et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano 2010; 4: 4609-4620.
28. Jy W, Ricci M, Shariatmadar S, et al. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011; 51: 886-893.
29. Salzer U, Hinterdorfer P, Hunger U, et al. Ca2+ dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VIII), and sorcin. Blood 2002; 99: 2569-2577.
30. Lopez JA, Del Conde I, Shrimpton CN. Receptors, rafts, and microvesicles in thrombosis and inflammation. J Thromb and Haemost 2005; 3: 1737-1741.
31. Del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-1611.